The Alzheimer’s Association puts the 2026 toll at 7.4 million Americans aged 65 or over. About 1 in 9 people in that age group, or 11%, has the disease. And the count is climbing fast.
It is also lopsided. Almost two-thirds of the people with the disease are women, and most patients are old: seventy-four percent are 75 or older. The risk is uneven across groups. Older Black Americans face roughly double the odds of older White Americans, and older Hispanic Americans roughly one and one-half times the odds. Age 65 is no hard border. Researchers believe about 200,000 Americans have younger-onset dementia, which the Association puts at roughly 110 cases per 100,000 people between 30 and 64.
A disease that kills
Memory loss is the symptom people know. The death toll gets less attention. For people 65 and older, Alzheimer’s officially ranked fifth among causes of death in 2024. Its deaths more than doubled from 2000 to 2024, while deaths from heart disease, the top killer, went down. Among older Americans, 1 in 3 dies with some form of dementia, Alzheimer’s included, a toll the Association says tops breast and prostate cancer put together.
After a diagnosis, people 65 and older live four to eight years on average. A few reach 20. A person who lives from 70 to 80 with the disease spends about 40% of that decade in the severe stage.
The bill
The money is large. Projected 2026 spending on health and long-term care for people with Alzheimer’s and other dementias is $409 billion, and that leaves out unpaid caregiving. Medicare and Medicaid should cover $263 billion of it, or 64%. Families will pay $103 billion out of pocket. By 2050 the total is projected to reach nearly $1 trillion.
Families carry more than the figures suggest. Nearly 13 million Americans give unpaid care to a relative or friend with dementia, work the Association values at $446.3 billion. About two-thirds of those caregivers are women. Fifty-nine percent describe their emotional stress as high or very high.
Washington moves
The federal response is shifting toward finding the disease before symptoms start. The Department of Health and Human Services has now revised its national plan on Alzheimer’s disease and related dementias, trimming the old six goals to four and stressing prevention and earlier detection, Healio reported on 28 October 2026. HHS also put as much as $48.8 million behind new projects. Most of it, as much as $41 million, goes to Mass General Brigham for a platform that uses blood tests to check whether drugs already approved for other conditions might work against Alzheimer’s.
The Association welcomed the focus on innovation and pressed Congress for the ASAP Act, a bill that would make Medicare pay for blood tests, cleared by the FDA, that screen for dementia. Without a medical breakthrough, the projection for 2060 is 13.8 million Americans over 65 living with the disease.
Sources
- Alzheimer's Facts and Figures Report | Alzheimer's Association
- Alzheimer's Facts and Figures Report | Alzheimer's Association
- HHS updates National Plan to Address Alzheimer’s Disease
- Alzheimer's Facts and Figures Report | Alzheimer's Association





